Glycyrrhetinic Acid-Effect on Serum Potassium and Insulin Resistance in Dialysis Patients

Clinical trial NCT00384384 · COMPLETED

Trial details

NCT number: NCT00384384
Sponsor: Insel Gruppe AG, University Hospital Bern
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

End Stage Renal Disease

Start date: 2006-08-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.